بنزبرومارون (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "بنزبرومارون" in Arabic language version.

refsWebsite
Global rank Arabic rank
4th place
6th place
2nd place
5th place

doi.org

  • Kumar، V.؛ Locuson، CW؛ Sham، YY؛ Tracy، TS (2006). "Amiodarone Analog-Dependent Effects on CYP2C9-Mediated Metabolism and Kinetic Profiles". Drug Metabolism and Disposition. ج. 34 ع. 10: 1688–96. DOI:10.1124/dmd.106.010678. PMID:16815961.
  • Hummel، M. A. (2005). "CYP2C9 Genotype-Dependent Effects on in Vitro Drug-Drug Interactions: Switching of Benzbromarone Effect from Inhibition to Activation in the CYP2C9.3 Variant". Molecular Pharmacology. DOI:10.1124/mol.105.013763.
  • Locuson، Charles W.؛ Rock، Denise A.؛ Jones، Jeffrey P. (2004). "Quantitative Binding Models for CYP2C9 Based on Benzbromarone Analogues†". Biochemistry. ج. 43 ع. 22: 6948–58. DOI:10.1021/bi049651o. PMID:15170332.
  • Locuson، Charles W.؛ Suzuki، Hisashi؛ Rettie، Allan E.؛ Jones، Jeffrey P. (2004). "Charge and Substituent Effects on Affinity and Metabolism of Benzbromarone-Based CYP2C19 Inhibitors". Journal of Medicinal Chemistry. ج. 47 ع. 27: 6768–76. DOI:10.1021/jm049605m. PMID:15615526.
  • Lee، Ming-Han H؛ Graham، Garry G؛ Williams، Kenneth M؛ Day، Richard O (2008). "A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout". Drug Safety. ج. 31 ع. 8: 643–65. DOI:10.2165/00002018-200831080-00002. PMID:18636784.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Sinclair، DS؛ Fox، IH (1975). "The pharmacology of hypouricemic effect of benzbromarone". The Journal of rheumatology. ج. 2 ع. 4: 437–45. PMID:1206675.
  • Kumar، V.؛ Locuson، CW؛ Sham، YY؛ Tracy، TS (2006). "Amiodarone Analog-Dependent Effects on CYP2C9-Mediated Metabolism and Kinetic Profiles". Drug Metabolism and Disposition. ج. 34 ع. 10: 1688–96. DOI:10.1124/dmd.106.010678. PMID:16815961.
  • Locuson، Charles W.؛ Rock، Denise A.؛ Jones، Jeffrey P. (2004). "Quantitative Binding Models for CYP2C9 Based on Benzbromarone Analogues†". Biochemistry. ج. 43 ع. 22: 6948–58. DOI:10.1021/bi049651o. PMID:15170332.
  • Locuson، Charles W.؛ Suzuki، Hisashi؛ Rettie، Allan E.؛ Jones، Jeffrey P. (2004). "Charge and Substituent Effects on Affinity and Metabolism of Benzbromarone-Based CYP2C19 Inhibitors". Journal of Medicinal Chemistry. ج. 47 ع. 27: 6768–76. DOI:10.1021/jm049605m. PMID:15615526.
  • Lee، Ming-Han H؛ Graham، Garry G؛ Williams، Kenneth M؛ Day، Richard O (2008). "A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout". Drug Safety. ج. 31 ع. 8: 643–65. DOI:10.2165/00002018-200831080-00002. PMID:18636784.